Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Debate

Why have total cholesterol levels declined in most developed countries?

Authors: Simon Capewell, Earl S Ford

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Our paper addresses three major public health issues: cholesterol, statins and policies to prevent cardiovascular disease.

Discussion

Total cholesterol levels in whole populations have fallen substantially in the USA, UK and most other developed countries. This has greatly contributed to decreases in cardiovascular disease deaths. The evidence identifying diet as the major contributor to these historical falls in cholesterol is powerful and consistent. Large falls occurred before statins were introduced. Additional substantial falls occurred before statins were widely used.
Now, up to 14% adults in Western populations currently receive statins for primary prevention. Furthermore, because diet is now only slowly improving, the statin contribution currently appears proportionately larger.

Summary

In conclusion, diet change explains most of the historical falls in cholesterol. Until very recently, the contribution from statins has been surprisingly modest. Furthermore, many middle income countries may have neither the resources nor the infrastructure for mass statin therapy.
Further substantial falls in cholesterol are therefore unlikely to be obtained simply by increased use of statins or dietary advice to individuals if unsupported by the wider environment. This further emphasises the need for more effective structural policies. Regulatory and fiscal interventions could easily eradicate industrial transfats, halve the intake of dietary saturated fat, and subsidise healthier fats.
Appendix
Available only for authorised users
Literature
1.
go back to reference Emerging Risk Factors Collaboration: Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009, 302: 1993-2000.CrossRef Emerging Risk Factors Collaboration: Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009, 302: 1993-2000.CrossRef
2.
go back to reference Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al: Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007, 356: 2388-98. 10.1056/NEJMsa053935.CrossRefPubMed Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al: Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007, 356: 2388-98. 10.1056/NEJMsa053935.CrossRefPubMed
3.
go back to reference Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH: Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol. 2010, 140: 226-35. 10.1016/j.ijcard.2008.11.033.CrossRefPubMed Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH: Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol. 2010, 140: 226-35. 10.1016/j.ijcard.2008.11.033.CrossRefPubMed
4.
go back to reference Eliasson M, Janlert U, Jansson JH, Stegmayr B: Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med. 2006, 260: 551-9. 10.1111/j.1365-2796.2006.01730.x.CrossRefPubMed Eliasson M, Janlert U, Jansson JH, Stegmayr B: Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med. 2006, 260: 551-9. 10.1111/j.1365-2796.2006.01730.x.CrossRefPubMed
5.
go back to reference Capewell S, O'Flaherty M, Ford ES, Critchley JA: Potential reductions in United States coronary heart disease mortality by treating more patients. Am J Cardiol. 2009, 103: 1703-9. 10.1016/j.amjcard.2009.02.036.CrossRefPubMed Capewell S, O'Flaherty M, Ford ES, Critchley JA: Potential reductions in United States coronary heart disease mortality by treating more patients. Am J Cardiol. 2009, 103: 1703-9. 10.1016/j.amjcard.2009.02.036.CrossRefPubMed
6.
go back to reference Mantel-Teeuwisse AK, Goettsch WG, Klungel OH, de BA, Herings RM: Long term persistence with statin treatment in daily medical practice. Heart. 2004, 90: 1065-6. 10.1136/hrt.2003.026187.CrossRefPubMedPubMedCentral Mantel-Teeuwisse AK, Goettsch WG, Klungel OH, de BA, Herings RM: Long term persistence with statin treatment in daily medical practice. Heart. 2004, 90: 1065-6. 10.1136/hrt.2003.026187.CrossRefPubMedPubMedCentral
7.
go back to reference Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366 (9493): 1267-78.CrossRefPubMed Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366 (9493): 1267-78.CrossRefPubMed
8.
go back to reference Heidemann C, Schulze MB, Franco OH, van Dam RM, Mantzoros CS, Hu FB: Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation. 2008, 118: 230-7. 10.1161/CIRCULATIONAHA.108.771881.CrossRefPubMedPubMedCentral Heidemann C, Schulze MB, Franco OH, van Dam RM, Mantzoros CS, Hu FB: Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation. 2008, 118: 230-7. 10.1161/CIRCULATIONAHA.108.771881.CrossRefPubMedPubMedCentral
9.
go back to reference Zatonski WA, Willett W: Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ. 2005, 331: 187-8. 10.1136/bmj.331.7510.187.CrossRefPubMedPubMedCentral Zatonski WA, Willett W: Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ. 2005, 331: 187-8. 10.1136/bmj.331.7510.187.CrossRefPubMedPubMedCentral
10.
go back to reference Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S: Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005, 162: 764-73. 10.1093/aje/kwi274.CrossRefPubMed Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S: Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005, 162: 764-73. 10.1093/aje/kwi274.CrossRefPubMed
11.
go back to reference Tugwell P, de Savigny D, Hawker G, Robinson V: Applying clinical epidemiological methods to health equity: the equity effectiveness loop. BMJ. 2006, 332: 358-61. 10.1136/bmj.332.7537.358.CrossRefPubMedPubMedCentral Tugwell P, de Savigny D, Hawker G, Robinson V: Applying clinical epidemiological methods to health equity: the equity effectiveness loop. BMJ. 2006, 332: 358-61. 10.1136/bmj.332.7537.358.CrossRefPubMedPubMedCentral
12.
13.
go back to reference Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF: Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005, 293: 1868-74. 10.1001/jama.293.15.1868.CrossRefPubMed Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF: Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005, 293: 1868-74. 10.1001/jama.293.15.1868.CrossRefPubMed
14.
go back to reference Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL: Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005, 294: 1773-81. 10.1001/jama.294.14.1773.CrossRefPubMed Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL: Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005, 294: 1773-81. 10.1001/jama.294.14.1773.CrossRefPubMed
15.
go back to reference Capewell S, Beaglehole R, Seddon M, McMurray J: Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation. 2000, 102: 1511-6.CrossRefPubMed Capewell S, Beaglehole R, Seddon M, McMurray J: Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation. 2000, 102: 1511-6.CrossRefPubMed
16.
go back to reference Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S: Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005, 162: 764-73. 10.1093/aje/kwi274.CrossRefPubMed Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S: Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005, 162: 764-73. 10.1093/aje/kwi274.CrossRefPubMed
17.
go back to reference Capewell S, Morrison CE, McMurray JJ: Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999, 81: 380-6.CrossRefPubMedPubMedCentral Capewell S, Morrison CE, McMurray JJ: Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999, 81: 380-6.CrossRefPubMedPubMedCentral
18.
go back to reference Unal B, Critchley JA, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004, 109: 1101-7. 10.1161/01.CIR.0000118498.35499.B2.CrossRefPubMed Unal B, Critchley JA, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004, 109: 1101-7. 10.1161/01.CIR.0000118498.35499.B2.CrossRefPubMed
19.
go back to reference Bennett K, Kabir Z, Unal B, Shelley E, Critchley J, Perry I, Feely J, Capewell S: Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health. 2006, 60: 322-7. 10.1136/jech.2005.038638.CrossRefPubMedPubMedCentral Bennett K, Kabir Z, Unal B, Shelley E, Critchley J, Perry I, Feely J, Capewell S: Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health. 2006, 60: 322-7. 10.1136/jech.2005.038638.CrossRefPubMedPubMedCentral
20.
go back to reference Palmieri L, Bennett K, Giampaoli S, Capewell S: Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health. 2010, 100: 684-92. 10.2105/AJPH.2008.147173.CrossRefPubMedPubMedCentral Palmieri L, Bennett K, Giampaoli S, Capewell S: Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health. 2010, 100: 684-92. 10.2105/AJPH.2008.147173.CrossRefPubMedPubMedCentral
21.
go back to reference Björck L, Rosengren A, Bennett K, Lappas G, Capewell S: Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009, 30: 1046-56. 10.1093/eurheartj/ehn554.CrossRefPubMed Björck L, Rosengren A, Bennett K, Lappas G, Capewell S: Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009, 30: 1046-56. 10.1093/eurheartj/ehn554.CrossRefPubMed
22.
go back to reference Aspelund T, Gudnason V, Magnusdottir BT, Andersen K, Sigurdsson G, Thorsson B, Steingrimsdottir L, Critchley J, Bennett K, O'Flaherty M, Capewell S: Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One. 2010, 5: e13957-10.1371/journal.pone.0013957.CrossRefPubMedPubMedCentral Aspelund T, Gudnason V, Magnusdottir BT, Andersen K, Sigurdsson G, Thorsson B, Steingrimsdottir L, Critchley J, Bennett K, O'Flaherty M, Capewell S: Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One. 2010, 5: e13957-10.1371/journal.pone.0013957.CrossRefPubMedPubMedCentral
23.
go back to reference Zaninotto P, Head J, Stamatakis E, Wardle H, Mindell J: Trends in obesity among adults in England from 1993 to 2004 by age and social class and projections of prevalence to 2012. J Epidemiol Community Health. 2009, 63: 140-6.CrossRefPubMed Zaninotto P, Head J, Stamatakis E, Wardle H, Mindell J: Trends in obesity among adults in England from 1993 to 2004 by age and social class and projections of prevalence to 2012. J Epidemiol Community Health. 2009, 63: 140-6.CrossRefPubMed
Metadata
Title
Why have total cholesterol levels declined in most developed countries?
Authors
Simon Capewell
Earl S Ford
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-641

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue